Clinical trial
A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared…
NCT00240006 · Teva Neuroscience, Inc., Industry · Completed
Key facts
| NCT number | NCT00240006 |
|---|---|
| Title | A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone |
| Official title | An Open Label, Prospective Parallel Cohort Study Comparing A 90-day Copaxone® Adherence Enhancement Program Among Persons With Multiple Sclerosis Who Participate in Shared Solutions® Alone or in Partnership With Their MS Center |
| Lead sponsor | Teva Neuroscience, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Procedure |
| Interventions | Shared Solutions® plus MS Center v. Shared Solutions® |
| Enrollment | 307 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Oct 17, 2005 |
| Last update posted | Apr 11, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: